BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2451993)

  • 1. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
    Tan DP; Tsou K
    Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
    Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
    Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of tachykinins injected intranigrally on striatal dopamine metabolism.
    Tan DP; Tsou K
    J Neurochem; 1988 Nov; 51(5):1333-7. PubMed ID: 2459306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
    Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intranigral substance P and neurokinin A on striatal dopamine release--II. Interactions with bicuculline and naloxone.
    Reid MS; Herrera-Marschitz M; Ungerstedt U
    Neuroscience; 1990; 36(3):659-67. PubMed ID: 1700330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
    Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
    Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
    Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional studies with the opioid peptide dynorphin: acute effects of injections into the substantia nigra reticulata of naive rats.
    Herrera-Marschitz M; Hökfelt T; Ungerstedt U; Terenius L
    Life Sci; 1983; 33 Suppl 1():555-8. PubMed ID: 6141500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J; Lenda T; Czarnecka A
    Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intranigral homocysteine administration produces stereotypic behavioral changes and striatal dopamine depletion in Sprague-Dawley rats.
    Chandra G; Gangopadhyay PK; Senthil Kumar KS; Mohanakumar KP
    Brain Res; 2006 Feb; 1075(1):81-92. PubMed ID: 16487496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats.
    Reid MS; Herrera-Marschitz M; Ungerstedt U
    J Neurochem; 1991 Sep; 57(3):970-4. PubMed ID: 1713616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
    Reid MS; Herrera-Marschitz M; Kehr J; Ungerstedt U
    Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates.
    Morelli M; Di Chiara G
    Brain Res; 1985 Aug; 341(2):350-9. PubMed ID: 2864100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The substance P(1-7) fragment is a potent modulator of substance P actions in the brain.
    Herrera-Marschitz M; Terenius L; Sakurada T; Reid MS; Ungerstedt U
    Brain Res; 1990 Jun; 521(1-2):316-20. PubMed ID: 1698511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the rat.
    Herrera-Marschitz M; Hökfelt T; Ungerstedt U; Terenius L; Goldstein M
    Eur J Pharmacol; 1984 Jul; 102(2):213-27. PubMed ID: 6148248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.